We are live on
!
Find out more
MS
Marshall & Sullivan Portfolio holdings
AUM
$216M
1-Year Est. Return
12.97%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$125M
AUM Growth
+$17M
(+16%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
10.98%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
42
New
2
Increased
6
Reduced
26
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$14.4M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$277K |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$122K |
| 4 |
State Street SPDR S&P Bank ETF
KBE
|
+$77.1K |
| 5 |
CELG
Celgene Corp
CELG
|
+$47.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$227K |
| 2 |
Stryker
SYK
|
+$99.9K |
| 3 |
Microsoft
MSFT
|
+$97.6K |
| 4 |
FISV
Fiserv Inc
FISV
|
+$96.3K |
| 5 |
Home Depot
HD
|
+$85.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.42% |
| 2 | Technology | 11.29% |
| 3 | Consumer Staples | 10.95% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
26
DELISTED
Celgene Corp
CELG
| $1.77M | 1.42% |
16,989
+421
| +3% | +$47.5K |
|
27
Gilead Sciences
GILD
$165B
| $1.62M | 1.3% |
22,639
+317
| +1% | +$24.1K |
|
|
28
Microsoft
MSFT
$2.9T
| $1.45M | 1.16% |
16,916
-1,190
| -7% | -$97.6K |
|
29
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $1.34M | 1.07% |
5,039
| – | – |
|
30
iShares Core S&P 500 ETF
IVV
$858B
| $1.34M | 1.07% |
5,000
| – | – |
|
31
Alphabet (Google) Class C
GOOG
$4.11T
| $1.21M | 0.97% |
23,080
-1,060
| -4% | -$54K |
|
32
Fortive
FTV
$18.2B
| $1.16M | 0.93% |
25,371
-656
| -3% | -$30K |
|
|
JWN
33
DELISTED
Nordstrom
JWN
| $988K | 0.79% |
20,843
-640
| -3% | -$27.6K |
|
34
Starbucks
SBUX
$119B
| $886K | 0.71% |
15,434
| – | – |
|
|
SRCL
35
DELISTED
Stericycle Inc
SRCL
| $776K | 0.62% |
11,409
-3,345
| -23% | -$227K |
|
36
Apple
AAPL
$4.97T
| $748K | 0.6% |
17,684
| – | – |
|
37
Eli Lilly
LLY
$1.08T
| $676K | 0.54% |
8,000
| – | – |
|
38
Costco
COST
$432B
| $299K | 0.24% |
1,605
| – | – |
|
|
39
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $284K | 0.23% |
+7,490
| New | +$277K |
|
40
iShares MSCI EAFE ETF
EFA
$76.4B
| $264K | 0.21% |
3,752
| – | – |
|
41
IBM
IBM
$213B
| $230K | 0.18% |
1,569
| – | – |
|
42
Chevron
CVX
$382B
| $228K | 0.18% |
1,825
-160
| -8% | -$19K |
|
Similar funds
DSN
ICM
FFAM
NWM
LA
APC
WTFG
SNWA
Marshall & Sullivan's Q4 2017 Portfolio in Review
As of Q4 2017, Marshall & Sullivan held 42 positions worth $125M, up 16% from $108M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Marshall & Sullivan deployed $13.7M of net new capital in Q4 2017, opening 2 new positions and adding to 6 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 96,056 shares worth $14.6M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Stericycle Inc, an estimated $227K trimmed.
- Marshall & Sullivan's largest Q4 2017 buy was iShares Russell 2000 ETF: 96,056 shares worth $14.6M.
- Marshall & Sullivan added most to Vanguard FTSE Emerging Markets ETF in Q4 2017, an estimated $122K increase.
- Marshall & Sullivan's biggest Q4 2017 reduction was Stericycle Inc, cutting an estimated $227K.
- Marshall & Sullivan's ten largest holdings make up 50% of its $125M portfolio in Q4 2017.
- Marshall & Sullivan opened 2 new positions and closed 0 in Q4 2017.
- Marshall & Sullivan's portfolio value rose 16% quarter-over-quarter to $125M.
Based on Marshall & Sullivan's 13F filing for Q4 2017, filed 9 Feb 2018.